Coloplast B A/S (COLO-B.CO)
Makes medical devices and supplies for people managing ostomies, incontinence, and wound care.
435.50+0.04%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-26.6%
The outlook
Coloplast trades near the lower end of its 52-week range, with analyst sentiment neutral and mixed momentum against moving averages. The average analyst target sits roughly 5% above the current price, while the stock carries a notably elevated P/E ratio of 46.7.
What’s behind the score
Analyst consensusHold — 3.1 avg of 21 analysts
Price trendMixed vs its moving averages
52-week range24% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 21 analysts458.24average target+5.2% vs now
Now 435.50
Low 345.00High 600.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
646.60
52-wk low
369.70
50-day avg
393.94
200-day avg
481.96
Trailing P/E
46.7